Sign in

CIK 0001513525 · Non-accelerated filer<br>Smaller reporting company

Azora Therapeutics, Inc. (DE)

Sign in to watch
Ticker
AZR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
800667150
Phone
434-422-9800
Business address
16501 VENTURA BLVD, SUITE 400, ENCINO, CA, 91436
Former names
ADIAL PHARMACEUTICALS, INC., Adial Pharmaceuticals, L.L.C., ADial Pharmaceuticals, L.L.C.
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 8-K Event Executive or director change · Other events
  5. 4 Conversion President and CEO acquired 626,252 shares (conversion)
  6. 4 Conversion Chief Strategy Officer acquired 626,252 shares (conversion)
  7. 4 Insider Changes in Ownership
  8. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  9. 4 Grant or award President and CEO acquired 232,417 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 8-K Event Executive or director change · Bylaws or fiscal year change · Shareholder vote results · Regulation FD disclosure
  13. EFFECT Other Notice of Effectiveness
  14. 10-Q/A Report 10-Q/A
  15. S-3/A Offering Registration Statement
  16. DEFA14A Proxy Proxy Materials
  17. 8-K Event Other events
  18. DEFA14A Proxy Proxy Materials
  19. 8-K Event Other events
  20. 4 Derivatives Options or other derivatives

Page 1 of 29 · 579 filings